Efficacy of the accelerated hepatitis B vaccination schedule used in haemodialysis patients post-exposure to virus: A single-centre experience

Nephrology Dialysis Transplantation

Volumn 17, Issue 11, 2002, Pages 1982-1987

  Eardley, Kevin S ^a   Jones, Helen E ^a   Osman, Husam ^a   Smith, Steve A ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chronic renal failure; Exposure; Hepatitis B; Recombinant hepatitis B vaccine

Indexed keywords

ERYTHROPOIETIN; HB VAX 2; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; STEROID; HEPATITIS ANTIBODY;

ADULT; AGE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CROSS INFECTION; DIABETES MELLITUS; DIALYSIS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENDER; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; STEROID THERAPY; VACCINATION; VACCINATION REACTION; AGED; ANTIBODY PRODUCTION; BLOOD TRANSFUSION; IMMUNIZATION; IMMUNOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TIME;

ADULT; AGED; ANTIBODY FORMATION; BLOOD TRANSFUSION; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; VACCINATION;

EID: 0036843989     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.11.1982     Document Type: Article

References (31)

1. Royal College of Physicians and Renal Association. Treatment of Adult Patients with Renal Failure. Recommended Standard and Audit Measures. Royal College of Physicians and Renal Association, 1997; 64-74
2. UK Department of Health. Immunisation Against lnfectious Disease 1996. HMSO, London, 1996
3. Center for Disease Control. Recommendations for preventing transmission of infection among chronic haemodialysis patients. M M W R 2001; 50: 1-43
4. Ray S, Samuel T, Hawker J, Smith SA. Hepatitis B immunisation in renal units in the United Kingdom. Br Med J 2002; 324: 877-878
5. UKRENALREG 1999. The Second Annual Report of the UK Renal Registry. UK Renal Registry, Bristol, 1999
6. PBHLS. Hepatitis B in retreat from dialysis units in United Kingdom in 1973. Public Health Laboratory Service survey. Br Med J 1976; 26: 1579-1581
7. Kohler H. Hepatitis B immunisation in dialysis patients-is it worth-while? Nephrol Dial Transplant 1994; 9: 1719-1720
8. Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic haemodialysis patients. Am J Kidney Dis 1999; 33: 356-360
9. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Defective expression of B7-2 (CD68) on monocytes of dialysis patients correlates to the uraemia associated immune defect. Kidney Int 2001; 59: 1382-1389
10. Stevens CE, Alter HJ, Taylor PE et al. Hepatitis B vaccine in patients receiving haemodialysis. N Engl J Med 1984; 311: 496-501
11. Bruguera M, Cremades M, Mayor A et al. Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients. Postgrad Med J 1987; 63 [Suppl 2]: 155-158
12. Sennesael JJ, Van Der Niepen P, Verbeelen DL. Treatment with recombinant human erythropoietin increases antibody titres after hepatitis B vaccination in dialysis patients. Kidney Int 1991; 40: 121-128
13. Lombardi M, Pizzarelli F, Righi M et al. Hepatitis B vaccination in dialysis patients and nutritional status. Nephron 1992; 61: 266-268
14. Navarro JF, Teruel JL, Mateos ML, Marcen R, Ortuno J. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection. Am J Nephrol 1996; 16: 95-97
15. Steketee RW, Ziarnik ME, Davis JP. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin. Am J Epidemiol 1988; 127: 772-782
16. Vagelli G, Calabrese G, Mazzotta A, Pratesi G, Gonella M. More about response to hepatitis B vaccine in hemodialysis patients. Nephron 1988; 49: 171
17. Stachowski J, Pollok M, Barth C, Maciejewski J, Baldamus CA. Non-responsiveness to hepatitis B vaccination in haemodialysis patients: association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition. Nephrol Dial Transplant 1994; 9: 144-152
18. el-Rashaid K, al-Mufti S, Johny KV, Sugathan TN. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine 1994; 12: 223-234
19. Fabrizi F, Di Filippo S, Marcelli D et al. Recombinant hepatitis B vaccine in chronic haemodialysis patients. Nephron 1996; 72: 536-543
20. Peces R, de la Torre M, Alcazar R, Urra JM. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in haemodialysis patients. Am J Kidney Dis 1997; 29: 239-245
21. Fernandez E, Betriu MA, Gomez R, Montoliu J. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidty and mortality. Nephrol Dial Transplant 1996; 11: 1559-1563
22. Mitwalli A. Responsiveness to hepatitis B vaccine in immuno-compromised patients by doubling the dose scheduling. Nephron 1996; 73: 417-420
23. Charest AF, McDougall J, Goldstein MB. A randomised comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic haemodialysis patients. Am J Kidney Dis 2000; 36: 976-982
24. Minuk GY, Genman GB, Bernstein KN et al. Failure of passively administered antibody to hepatitis B surface antigen to augment the immune response of a low-responder population. Clin Invest Med 1994; 71: 61-65
25. Evans TG, Schiff M, Graves B et al. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic haemodialysis patients who have failed primary vaccination. Clin Nephrol 2000; 54: 138-142
26. Deniz Ayli M, Ensari C, Ayli M, Mandiroglu F, Mut S. Effect of oral levamisole supplementation to hepatitis B vaccination on the rate of immune response in chronic hemodialysis patients. Nephron 2000; 84: 291-292
27. Rangel MC, Coronado VG, Euler GL, Strikas RA. Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Semin Dial 2000; 13: 101-107
28. Alter MJ, Favero MS, Francis DP. Cost benefit of vaccination of hepatitis B in hemodialysis centers. J Infect Dis 1983; 148: 770-771
29. Oddone EZ, Cowper PA, Hamilton JD, Feussner JR. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. Health Serv Res 1993; 28: 97-121
30. Lee WC, Shu KH, Cheng CH et al. Long-term impact of hepatitis B, C virus infection on renal transplantation. Am J Nephrol 2001; 21: 300-306
31. Dukes CS, Street AC, Starling JF, Hamilton JD. Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis. Vaccine 1993; 11: 1229-1232